Skip to main content

Month: August 2020

BriaCell Therapeutics Corp. Announces Completion of Shares for Debt Issuance

BERKELEY, Calif. and VANCOUVER, British Columbia, Aug. 17, 2020 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (“BriaCell” or the “Company”) (TSX-V:BCT) (OTCQB:BCTXF), a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced breast cancer, announces that further to its news release dated August 11, 2020, it has received the approval of the TSX Venture Exchange for the shares for debt transaction, to settle the aggregate of $374,000 in indebtness of the Company, through the issuance of 50,000 common shares of the Company (each, a “Share“) at a deemed price of $7.48 per Share (“Debt Settlement“).All securities issued pursuant to the Debt Settlement are subject to a hold period of four-months and one day.About BriaCellBriaCell is an immuno-oncology focused...

Continue reading

Lamar Advertising Company Prices Private Offering of an Additional $150 Million of 4% Senior Notes due 2030

BATON ROUGE, La., Aug. 17, 2020 (GLOBE NEWSWIRE) — Lamar Advertising Company (Nasdaq: LAMR) announced today that its wholly owned subsidiary, Lamar Media Corp (“Lamar Media”), has agreed to sell $150.0 million of additional 4% Senior Notes due 2030 (the “Notes”) through an institutional private placement. The Notes are being issued as additional notes to the existing $400.0 million aggregate principal amount of ‎4% Senior Notes due 2030 that Lamar Media issued on February 6, 2020 (the “Existing Notes”). Other than with respect to the date of issuance and issue price, the Notes will have the same terms as the Existing Notes.‎ The Notes will be maintained under the same CUSIP numbers as the Existing Notes (except that the Notes ‎issued pursuant to Regulation S will trade separately under a different CUSIP number until 40 days after...

Continue reading

First Patient Dosed in Phase I/II Trial of Renal Cancer Imaging Product in Japan

TOKYO, Aug. 18, 2020 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Japan K.K., a wholly-owned subsidiary of Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) is pleased to announce that the first patient has been dosed in a Phase I/II study of Telix’s renal cancer diagnostic imaging product TLX250-CDx (89Zr-girentuximab) in Japan.The objective of the study, termed the “ZIRDAC-JP” (Zirconium Dosing and Comparison in Japan) study is to confirm the safety and tolerability, as well as sensitivity and specificity of positron emission tomography (PET) imaging with TLX250-CDx to detect clear cell renal cell cancer (ccRCC) in Japanese patients. The patient population for the ZIRDAC-JP trial has been selected to be identical to the global Phase III ZIRCON trial, with comparison to surgical resection (histology) as standard of truth....

Continue reading

California Water Service Prepared for Power Outages

SAN JOSE, Calif., Aug. 17, 2020 (GLOBE NEWSWIRE) — As much of the state is enduring rolling power outages to ease demand on the electrical grid, California Water Service (Cal Water) is reassuring its customers that it is taking all possible steps to prevent any interruptions in water service due to the power outages.The utility has been installing permanent generators at critical stations over recent years and has positioned additional, portable backup generators at key stations to keep water flowing if power is interrupted. Cal Water is also monitoring local water system levels and has activated its Emergency Operations Center to help mobilize extra personnel needed to support any district.Because delivering water requires a significant amount of electricity, Cal Water is also urging customers to conserve water during this time...

Continue reading

Targa Resources Partners LP Announces Expiration and Final Results of Tender Offer for Its 6.750% Senior Notes due 2024

HOUSTON, Aug. 17, 2020 (GLOBE NEWSWIRE) — Targa Resources Partners LP (“Targa Resources Partners” or the “Partnership”), a subsidiary of Targa Resources Corp. (NYSE:TRGP) announced today that its previously announced cash tender offer (the “Tender Offer”) to purchase any and all of its 6.750% senior notes due 2024 (the “2024 Notes”) expired at 5:00 p.m., New York City time, on August 17, 2020 (the “Expiration Time”). As of the Expiration Time, $262,131,000 aggregate principal amount of the 2024 Notes (45.2%) were validly tendered, which excludes $14,143,000 aggregate principal amount of the 2024 Notes that remain subject to guaranteed delivery procedures. Targa Resources Partners expects to accept for payment all such 2024 Notes validly tendered and not validly withdrawn in the Tender Offer and expects to make payment for the 2024...

Continue reading

BE Resources Announces Letter of Intent to Acquire Bio Graphene Solutions Inc.

TORONTO, Aug. 17, 2020 (GLOBE NEWSWIRE) — BE Resources Inc. (TSXV: BER.H) (“BE Resources” or the “Company”) announces that has signed a non-binding letter of intent dated August 17, 2020 (the “LOI“) with Bio Graphene Solutions Inc. (“BGS“), a private company incorporated under the Canada Business Corporations Act (the “CBCA“), which sets forth the general terms and conditions of a proposed reverse takeover transaction (the “Acquisition“). In addition and in connection with the Proposed Transaction, the parties have agreed that as a condition of closing, BGS or the Company will complete a private placement of common shares for a minimum raise of C$600,000 at a price of at least $0.15 in accordance with subsection 4.2(h) of Policy 5.4 of the TSX Venture Exchange (the “Exchange“)...

Continue reading

LiveWire Ergogenics Reports Second Quarter 2020 Results and Prepares for Full Operation on Paso Robles Ranch Property

Anaheim, CA, Aug. 17, 2020 (GLOBE NEWSWIRE) — LiveWire Ergogenics Inc. (OTC: LVVV), a company focused on acquiring and managing special purpose real estate properties conducive to producing the highest-quality, organically-grown and handcrafted cannabis products for medicinal and recreational use in California, today announced its financial results for Q2 ending June 30, 2020.During the quarter ending June 30, 2020, sales amounted to $180,500, an increase of of 28% over the previous quarter in 2020. Revenues in the first two quarters of 2020 do not reflect revenues generated through GHC Ventures. The three and six months revenue for 2019 has been adjusted retroactively to $17,980 to reflect that revenues for GHC Ventures are not being recognized in our financial reporting based on the sale of GHC Ventures, and its treatment as a...

Continue reading

INV Metals Reports Passing of Director Mr. James Clucas

TORONTO, Aug. 17, 2020 (GLOBE NEWSWIRE) — INV Metals (“INV Metals” or “Company”) (TSX: INV) provides an update on corporate matters. INV Metals holds a 100% interest in the Loma Larga gold-copper-silver property (“Loma Larga” or “Project”), located in Ecuador.Ms. Candace MacGibbon, CEO, stated, “It is with deep sadness that we report the passing of Mr. James (Jim) Clucas, co-founder and director of INV Metals. Jim was passionate about the mining industry and held directorships in many junior mining companies pursuing his love of the business. Mr. Clucas was CFO of Inco Limited’s Canadian operations until 1984 and was involved in the development of several mineral deposits, including the Snow Lake Mine, Montana Tunnels and the Fenix Project. The Board of Directors would like to extend our sincere condolences...

Continue reading

Xcel Brands Reschedules Second Quarter 2020 Financial Results to August 20, 2020

NEW YORK, Aug. 17, 2020 (GLOBE NEWSWIRE) — Xcel Brands, Inc. (NASDAQ: XELB) (“Xcel” or the “Company”), a media and consumer products company, today announced that it will report its second quarter 2020 financial results after the market closes on August 20, 2020. The Company will hold a conference call with the investment community at 5:00 p.m. Eastern Time that day. The earnings release was rescheduled from the original date of August 18, 2020.A webcast of the conference call will be available live on the Investor Relations section of Xcel’s website at https://www.xcelbrands.com/. Interested parties unable to access the conference call via the webcast may dial 877-407-3982. A replay of the conference call will be available on the Company website for approximately two weeks following the event and can be accessed at 844‑512‑2921...

Continue reading

Platinex Inc. Announces the Appointment of a New Chief Financial Officer

TORONTO, Aug. 17, 2020 (GLOBE NEWSWIRE) — Platinex Inc. (CSE: PTX) (the “Company” or “Platinex“) is pleased to announce that Mr. Graham Warren has been appointed as Chief Financial Officer and Corporate Secretary of the Company, effective today, and that Mr. Carmelo Marrelli has resigned, effective today.  Ms. Lori Paradis, is assuming the role of Assistant Secretary.Mr. Warren is a Chartered Professional Accountant specializing in resource-focused, operations and finance. Mr. Warren has accumulated extensive experience working as CFO and Director of TSX Venture Exchange and CSE listed resource companies.He has been involved in numerous financings and M&A transactions for both private and public companies and has guided several companies through the going public process. Mr. Warren has had extensive...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.